Article Details
Retrieved on: 2022-07-08 13:35:05
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Carnegie Mellon University has licensed a proprietary platform for bioengineering exosomes for drug delivery to Coya Therapeutics, Inc. Through ...
Article found on: www.miragenews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here